Drug Profile
AB 101 - Safety Shot
Alternative Names: AB-101 - Safety Shot; RJ-101Latest Information Update: 27 Feb 2024
Price :
$50
*
At a glance
- Originator Applied Biology
- Developer Safety Shot
- Class Bacteria; Gene therapies; Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Alopecia; Female sexual dysfunction
Most Recent Events
- 28 Sep 2022 No recent reports of development identified for research development in Alopecia in USA (Topical)
- 28 Aug 2021 No recent reports of development identified for phase-I development in Female-sexual-dysfunction(In volunteers) in USA (Topical)
- 03 Aug 2018 Early research in Alopecia in USA (Topical) before August 2018 (Applied Biology website, August 2018)